APPLIED THERAPEUTICS INC. - COMMON STOCK
4.7600
03-May-24 15:59:57
15 minutes delayed
Stocks
+0.2300
+5.08%
Today's range
4.6050 - 4.8600
ISIN
N/A
Source
NASDAQ
-
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
15 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Announces $100 Million Private Placement
28 Feb 2024 08:05:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Third Quarter 2023 Financial Results
09 Nov 2023 07:30:54 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the UBS Biopharma Conference 2023
02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
01 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
28 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Second Quarter 2023 Financial Results
10 Aug 2023 07:00:44 By Nasdaq GlobeNewswire
-
22 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
25 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports First Quarter 2023 Financial Results
11 May 2023 07:00:35 By Nasdaq GlobeNewswire
-
Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity
24 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >